TY - JOUR
T1 - Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma
T2 - a LEO cohort study analysis
AU - Abro, Brooj
AU - Maurer, Matthew J.
AU - Habermann, Thomas M.
AU - Burack, W. Richard
AU - Chapman, Jennifer R.
AU - Cohen, Jonathon B.
AU - Friedberg, Jonathan W.
AU - Inghirami, Giorgio
AU - Kahl, Brad S.
AU - Larson, Melissa C.
AU - Link, Brian K.
AU - Lossos, Izidore S.
AU - Martin, Peter
AU - McDonnell, Timothy J.
AU - Nastoupil, Loretta J.
AU - Riska, Shaun M.
AU - Syrbu, Sergei
AU - Vega, Francisco
AU - Vij, Kiran R.
AU - Flowers, Christopher R.
AU - Cerhan, James R.
AU - Jaye, David L.
AU - Feldman, Andrew L.
N1 - Publisher Copyright:
© 2024 American Society of Hematology
PY - 2024/11/7
Y1 - 2024/11/7
N2 - Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.
AB - Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that differences between the classifications will affect <1% of non-Hodgkin lymphomas.
UR - http://www.scopus.com/inward/record.url?scp=85205349351&partnerID=8YFLogxK
U2 - 10.1182/blood.2024025681
DO - 10.1182/blood.2024025681
M3 - Article
C2 - 39255410
AN - SCOPUS:85205349351
SN - 0006-4971
VL - 144
SP - 2063
EP - 2066
JO - Blood
JF - Blood
IS - 19
ER -